Expansion Therapeutics
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
555 Heritage Dr Ste 150, Jupiter, Florid...Website
www.expansionrx.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
1
1
1
About Expansion Therapeutics
Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases including neurodegenerative disorders. The company is based in Boston, Massachusetts.Explore more
Expansion Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Expansion Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Expansion Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Expansion Therapeutics has new funding data
Earning: See what the market has to say on Expansion Therapeutics recently announced quarterly report
Expansion Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Expansion Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Expansion Therapeutics launches new products
Check out if Expansion Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Expansion Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Expansion Therapeutics
Compare insights from companies similar to Expansion Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Expansion Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Expansion Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Expansion Therapeutics.
Expansion Therapeutics financials insights
Gather financial insights about Expansion Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$55.3M
2021
Series B
$80M
Expansion Therapeutics Tech Stack
A closer look at the technologies used by Expansion Therapeutics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Board of Directors
Open Position
Open Position
Expansion Therapeutics News & Media
Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
BOSTON--(BUSINESS WIRE)--Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the appointment of Raymond J. Kelleher, M.D., Ph.D., to its Board of Directors representing Cormorant Asset Management. Dr. Kelleher is an accomplished neurologist and neuroscientist, company founder, and investor, who serves on several boards for leading biotechnology and pharmaceutical companies. “We are delightedExpansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development
BOSTON--(BUSINESS WIRE)--Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the appointment of Sudhir Rao, M.S., M.B.A., to the position of Senior Vice President of Business Development. “We are delighted to welcome Sudhir to Expansion and look forward to benefiting from his extensive business development experience and strong R&D background as we advance our portfolio of small moleculeExpansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board of Directors
BOSTON--(BUSINESS WIRE)--Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the appointment of Gary Bridger, Ph.D., to its Board of Directors, serving as an independent director. Dr. Bridger has more than 30 years of experience in research and development and a breadth of management and operational experience, having served in senior leadership positions and on the boards for several leadingExpansion raises $80 million to drug RNA | C&EN Global Enterprise - ACS Publications
Expansion Therapeutics has raised $80 million in series B financing to develop small-molecule drugs that target RNA. The start-up is based on the work of its founder, Scripps Research chemist Matth...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Expansion Therapeutics
Sign Up For FreeTo access detailed company insights
Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases including neurodegenerative disorders. The company is based in Boston, Massachusetts.... Read More
